https://www.selleckchem.com/pr....oducts/gsk1838705a.h
We appreciate the interest by Moura and colleague in our editorial regarding the role of the rheumatologist during the Covid-19 pandemic (1). The letter by Drs. Carlos Antonio Moura and Ana Luísa Cerqueira de Sant'Ana Costa emphasizes the need to understand mechanisms of disease underlying the more serious complications of Covid-19 infection as well as provide the best treatment possible to large numbers of seriously ill patients during a global pandemic (2).We would like to share ideas on the report "Hydroxychloroquine in Patients